Abstract
Healthcare workers are at increased risk of exposure to COVID-19. The majority of cases are acquired through inhalation of infected respiratory particles, contamination with infected surfaces or whilst performing aerosol-generating procedures. Basic infection prevention measures are essential to protect healthcare workers from contracting the disease when managing patients; consequently global demand for personal protective equipment (PPE) has exceeded supply in many regions. We present a novel, innovative polycarbonate shield designed for ENT clinicians performing tracheostomies. Clinical investigations using the shield demonstrated a sixteen-fold decrease in the number of particles detected at the position of the operating surgeon when the shield was used (particle size 0.3μm; with shield 27,000 versus 439,000 without shield). The shield, used with appropriate PPE, could therefore help to minimise exposure to aerosol generated particles such as during tracheostomies on patients with COVID-19.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors of this paper received no specific grant from any funding agency in the public, commercial or not-for-profit sectors. There has been no financial support for this work that could have influenced its outcome. Manufacturing of the shield was supported by funds from crowd-funding.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Acknowledgements We would like to thank Matthew Buckley, Abplas, for his design skills, time and determination to help create the St George’s shield. We would also like to thank the ENT surgeons and theatre staff at St George’s University Hospital, for using and providing feedback on the shield. Our thanks also to Mr. Darren Lui, Trauma and Orthopaedic Surgeon, St George’s University Hospital, for sharing his experience of and allowing us to use his particle counter.
Data Availability
The authors confirm that the data supporting the findings of this study are available within the article.